U.S. Healthtech Stock News

NYSE:UNP
NYSE:UNPTransportation

Surface Transportation Ruling Reframes Union Pacific Intermodal Partnerships And Merger Expectations

The Surface Transportation Board denied Union Pacific's request for an investigation into Canadian Pacific Kansas City's handling of interline intermodal trains on the Meridian Speedway. Regulators indicated that service issues on the corridor linking the U.S. West Coast and Southeast have been resolved. The decision clarified that gateway conditions from a recent rail merger do not apply to this intermodal traffic. The ruling shapes the operational and competitive setting for Union Pacific...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance NFL Talks Could Reframe Value Gap And Growth Story

Paramount Skydance, ticker NasdaqGS:PSKY, is in advanced talks to extend its exclusive NFL Sunday football broadcasting agreement. The potential extension would add roughly $1 billion to the contract value and run through the 2033–2034 season. The revised deal is expected to remove a key opt-out clause, tightening the partnership between Paramount Skydance and the NFL. For investors watching media and streaming, this development touches the core of Paramount Skydance's content engine. Live...
NYSE:LNC
NYSE:LNCInsurance

Assessing Lincoln National’s Valuation After Recent Share Price Weakness

What Lincoln National’s Recent Returns Are Signaling Lincoln National (LNC) has drawn investor attention after a rough patch, with the stock showing a 4.1% decline over the past week, about 20% over the past month, and 28% over the past 3 months. See our latest analysis for Lincoln National. Set against the recent pullback, Lincoln National’s 1 year total shareholder return decline of 7.6% and 3 year total shareholder return of 83.5% suggest longer term holders have still seen meaningful...
NYSE:FMC
NYSE:FMCChemicals

Should FMC’s Governance Changes and Legal Scrutiny Require Action From FMC (FMC) Investors?

FMC Corporation has proposed amendments to its certificate of incorporation and by-laws, including removing supermajority voting provisions and granting stockholders holding 25% of shares the right to call special meetings, following prior announcements about exploring strategic options and facing an investor law firm investigation into potential securities law violations. Taken together, these governance moves and legal scrutiny point to rising shareholder influence over FMC’s future...
NasdaqGS:TBBK
NasdaqGS:TBBKBanks

Assessing Bancorp (TBBK) Valuation After Recent Share Price Pullback And Fintech Growth Story

Bancorp stock: quick context for recent moves Bancorp (TBBK) has drawn fresh attention after recent trading, with the share price at US$53.55 and returns showing a 9% decline over the past month and a 21% decline over the past 3 months. See our latest analysis for Bancorp. That recent pullback sits alongside a weaker short term share price return and a much stronger multi year total shareholder return, which together suggest momentum has faded for now even though long term holders have still...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron’s Taiwan DRAM Expansion Weighs On AI Demand And Rich Valuation

Micron Technology (NasdaqGS:MU) has completed its acquisition of the Tongluo P5 site in Taiwan from Powerchip Semiconductor Manufacturing Corp. The company plans to build a second DRAM manufacturing facility at the Tongluo P5 location to address AI related memory demand. The Taiwan expansion is part of Micron's wider buildout that also includes new capacity in India and the U.S. for AI infrastructure products. Micron Technology focuses on memory and storage products that sit at the core of...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck Readies For Keytruda Cliff With New Drivers And mRNA Vaccines

Merck, NYSE:MRK, has outlined a broad plan to limit the revenue impact as Keytruda approaches loss of exclusivity. The company is targeting more than 20 new human health growth drivers, with a focus on oncology and cardiovascular therapies. Merck and Moderna are progressing personalized mRNA cancer vaccines, supported by five year data and the start of Phase 3 trials. These efforts sit alongside ongoing business development and new partnerships as biosimilar competition to Keytruda draws...
NYSE:VVV
NYSE:VVVSpecialty Retail

Assessing Whether Valvoline (VVV) Looks Undervalued After Mixed Recent Share Price Returns

What recent returns say about Valvoline (VVV) With no single headline event driving attention, Valvoline (VVV) has still been on many watchlists as investors reassess auto maintenance retailers after a mixed stretch of short term and longer term returns. Over the past month, Valvoline shares show a 12.8% decline, while the past 3 months reflect a 9.2% gain. Year to date, the stock is up 16.4%, with a 1 year total return of a 7.1% decline. Looking further back, the 3 year total return sits...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Is The Recent Slide In Navan (NAVN) Creating A Potential Opportunity For Investors

Investors may be wondering if Navan at around US$8.90 is starting to look interesting on value, or if the recent price action is a warning sign. The stock has seen a 10% decline over the last 7 days and a 14.8% decline over the last 30 days, contributing to a 45.2% drop year to date, which can change how the market is thinking about both upside and risk. Recent coverage of Navan has focused on how the market is reassessing newer listings and higher risk names, with investors paying closer...
NYSE:HP
NYSE:HPEnergy Services

A Look At Helmerich & Payne (HP) Valuation As Private Shale Rig Demand Shifts In Its Favor

Helmerich & Payne (HP) is back in focus after its board declared a quarterly cash dividend of $0.25 per share, payable on June 1, 2026, to shareholders of record on May 18. See our latest analysis for Helmerich & Payne. The latest dividend decision comes as investor interest has already been rising, with a 30.39% 90 day share price return and 19.07% year to date share price return at a last close of $35.65. The 1 year total shareholder return of 47.05% points to momentum that has been...
NYSE:WCN
NYSE:WCNCommercial Services

Is Waste Connections (WCN) Attractive After Recent Share Price Weakness And Mixed Valuation Signals

If you are wondering whether Waste Connections at around US$166 per share still offers fair value, the key is to separate short term noise from what the current price actually reflects. The stock has seen a 3.0% gain over the last 30 days, but that sits against a 4.4% year to date decline and a 10.7% decline over the past year, which naturally raises questions about how the market is reassessing its prospects and risks. Recent attention on the commercial services space, including Waste...
NYSE:RHP
NYSE:RHPHotel and Resort REITs

Does Ryman Hospitality Properties' (RHP) 2034 Refi Reveal a New Playbook for Balance Sheet Flexibility?

Earlier this month, Ryman Hospitality Properties and its affiliates issued US$700 million of 5.750% senior unsecured notes due 2034 under a new indenture, with the company planning to use the proceeds and available cash to redeem in full its existing US$700 million 4.750% senior notes due 2027. This refinancing not only pushes out a major maturity but also tightens operating and financing covenants, reshaping Ryman’s balance sheet flexibility and creditor protections through 2034. Next,...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Plans Largest Layoffs As AI Spending Reshapes Long-Term Earnings Path

Meta Platforms, NasdaqGS:META, is planning its largest ever round of layoffs, potentially affecting 20% or more of its workforce. The potential reduction of up to 15,800 roles is tied directly to the company’s push into AI infrastructure, custom chips, and expanded data centers. Management is framing the cuts as a way to reallocate resources toward AI, with an emphasis on efficiency and doing more with fewer employees. For investors watching NasdaqGS:META at around $613.71, this planned...
NYSE:PGR
NYSE:PGRInsurance

Did Progressive's (PGR) CFO Transition and Dividend Move Just Reframe Its Capital Allocation Story?

Earlier this month, Progressive’s board declared a US$0.10 per-share common dividend, payable on April 10, 2026, to shareholders of record as of April 2, 2026, underscoring its ongoing capital return program. At the same time, Progressive announced the upcoming retirement of long-serving CFO John Sauerland and the planned handover to current Chief Strategy Officer Andrew Quigg, a leadership shift that could shape how the insurer balances growth investments, pricing discipline, and...
NYSE:UBER
NYSE:UBERTransportation

Uber Expands From Rides To Parking And Autonomous Partner Platform

Uber Technologies (NYSE:UBER) agreed to acquire parking platform SpotHero, adding in app parking reservations to its mobility offering. Uber introduced Uber Autonomous Solutions, a new platform aimed at supporting robotaxi and autonomous delivery partners globally. The two announcements mark an expansion of Uber’s services beyond ride hailing and delivery into parking and broader autonomous vehicle enablement. For investors following NYSE:UBER, these moves highlight how the company is...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Valuation Check After Recent Share Price Momentum And Mixed Fair Value Signals

Why Kinder Morgan is on investors’ radar today Kinder Morgan (KMI) is drawing attention after recent performance data showed a 3.3% return over the past month and a 26.8% total return over the past 3 months, against a last close of US$33.39. See our latest analysis for Kinder Morgan. That recent 3 month share price return sits alongside a 20.5% year to date share price return and a 25.3% 1 year total shareholder return, suggesting momentum has been building over both shorter and longer...
NYSE:AON
NYSE:AONInsurance

Aon (AON) Valuation Check After Stablecoin Insurance Premium Breakthrough With Coinbase And Paxos

Aon (AON) recently completed what it describes as the first stablecoin insurance premium payment among major global brokers, using USDC on Ethereum and PayPal USD on Solana with clients Coinbase and Paxos. See our latest analysis for Aon. At a share price of $321.41, Aon has seen recent momentum soften, with a 90 day share price return of 8.64% and a 1 year total shareholder return of 17.09%. The 5 year total shareholder return of 49.65% points to meaningfully stronger long run compounding...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

Why Andersons (ANDE) Is Up 7.7% After Earnings Beat And Middle East Grain Supply Shock – And What's Next

The Andersons, Inc. recently reported quarterly earnings that exceeded analyst expectations on earnings per share even as revenue fell year-on-year, while its CEO’s 2025 compensation rose to an estimated US$5,472,539 alongside insider stock sales and shifting institutional positions. At the same time, Middle East shipping disruptions have tightened global grain and fertilizer supply, lifting prices and potentially improving margin prospects for Andersons’ Agribusiness and Renewables...
NYSE:FCN
NYSE:FCNProfessional Services

Is It Time To Reassess FTI Consulting (FCN) After Recent Share Price Weakness

Wondering if FTI Consulting at around US$162.58 is fairly priced, too expensive, or offering value right now? This article walks through the key signals you can use to judge that for yourself. The stock has been under some pressure recently, with a 3.0% decline over the last week, a flat 0.1% slip over the past month, and returns of 4.5% lower year to date and 0.7% lower over the past year, even though the 5 year return sits at 18.5%. These moves sit against a backdrop of ongoing interest in...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

The Bull Case For HealthEquity (HQY) Could Change Following Q4 FY26 Earnings Beat Test - Learn Why

HealthEquity recently reported its Q4 fiscal 2026 results after Wall Street had forecast earnings of US$0.89 per share on revenue of US$332.85 million, with expectations for earnings growth and continued expansion in its health savings account and benefits administration business. Investor attention has centered on whether HealthEquity could extend its pattern of topping consensus estimates, making this earnings release a key indicator of the company’s ability to sustain account growth and...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Is Commvault (CVLT) Quietly Reframing Its Cybersecurity Edge Around Identity Resilience?

Earlier this month, Commvault announced an integration with CloudSEK that feeds dark web credential intelligence into its Active Directory security tools, alongside an expansion of its Identity Resilience portfolio to support rapid recovery of Okta environments from misconfigurations, disruptions, and identity-driven attacks. Together, these moves highlight Commvault’s push deeper into identity-centric cyber resilience, aiming to tie external credential exposure data directly to internal...
NYSE:ARMK
NYSE:ARMKHospitality

Is Aramark’s (ARMK) Southeast Push and A’s Deal Reframing Its Sports Hospitality Ambitions?

In early March 2026, Aramark Refreshments opened its first Alabama Market Center in Madison and Aramark Sports + Entertainment partnered with the Las Vegas A’s and restaurateur Will Guidara on premium hospitality concepts for the team’s planned 2028 ballpark. Together, these moves extend Aramark’s on-the-ground presence in the Southeast while deepening its role in high-end sports hospitality, linking local workforce initiatives with upscale, experience-led offerings. We’ll now examine how...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

A Look At RadNet (RDNT) Valuation After Barclays Conference AI Growth Outlook

RadNet (RDNT) is back in focus after executives used the Barclays Global Healthcare Conference to outline 2026 targets for revenue and EBITDA growth, centered on advanced imaging and broader use of AI-enabled solutions. See our latest analysis for RadNet. After a sharp share price pullback in recent months, including a 10.7% 1 month share price return and 12.8% 3 month share price return, RadNet’s 1 year total shareholder return of 26.7% and very large 5 year total shareholder return suggest...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

A Look At Ocular Therapeutix (OCUL) Valuation After Recent Share Price Weakness

What Stands Out About Ocular Therapeutix Right Now Ocular Therapeutix (OCUL) has drawn fresh attention after a period where the share price shows mixed returns, including a 1 day decline of 1.2% and a loss of 14.7% over the past week. At a recent close of US$8.76 and a market value of about US$1.9b, the company sits at an interesting point for investors comparing its current pricing with its business profile and recent financial results. See our latest analysis for Ocular Therapeutix. The...